Concepedia

Alexander C. Robeson

AC

Statistics

Publications

6

Citations

342

H-Index

6

Active since

2013

Affiliations

Duke Medical Center(Current)

Duke University Hospital

University of North Carolina at Chapel Hill

Alexander C. Robeson is an author at Duke Medical Center specializing in medicine, cell death, and cell signaling.

ORCID

Top concepts

Publications per year

2013–2022

6

Publications

6

STING agonist promotes CAR T cell trafficking and persistence in breast cancer

Nuo Xu, Douglas C. Palmer, Alexander C. Robeson et al. · The Journal of Experimental Medicine · 2020 · 181 citations · Full text

, , +13

Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death

C-S. Yang, Kenkyo Matsuura, N-J Huang et al. · Oncogene · 2014 · 48 citations · Full text

, , +7

Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis

Erika Segear Johnson, Kelly Lindblom, Alexander C. Robeson et al. · Journal of Biological Chemistry · 2013 · 45 citations · Full text

, , +7

Dimer‐specific immunoprecipitation of active caspase‐2 identifies TRAF proteins as novel activators

Alexander C. Robeson, Kelly Lindblom, Jeffrey Wojton et al. · The EMBO Journal · 2018 · 28 citations · Full text

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer

Carey K. Anders, Mark G. Woodcock, Amanda E.D. Van Swearingen et al. · Journal for ImmunoTherapy of Cancer · 2022 · 26 citations · Full text

Rows per page

1–5 of 6